IKK is a therapeutic target in KRAS-induced lung cancer with disrupted p53 activity (2014)
- Authors:
- Autor USP: BASSÈRES, DANIELA SANCHEZ - IQ
- Unidade: IQ
- Subjects: ONCOGENES; NEOPLASIAS DO TRATO RESPIRATÓRIO
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Genes & Cancer
- ISSN: 1947-6027
- Volume/Número/Paginação/Ano: v. 5, n. 1-2, p. 41-55, 2014
-
ABNT
BASSÈRES, Daniela Sanchez et al. IKK is a therapeutic target in KRAS-induced lung cancer with disrupted p53 activity. Genes & Cancer, v. 5, n. 1-2, p. 41-55, 2014Tradução . . Disponível em: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4063255/pdf/ganc-05-041.pdf. Acesso em: 24 abr. 2024. -
APA
Bassères, D. S., Ebbs, A., Cogswell, P. C., & Baldwin, A. S. (2014). IKK is a therapeutic target in KRAS-induced lung cancer with disrupted p53 activity. Genes & Cancer, 5( 1-2), 41-55. Recuperado de http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4063255/pdf/ganc-05-041.pdf -
NLM
Bassères DS, Ebbs A, Cogswell PC, Baldwin AS. IKK is a therapeutic target in KRAS-induced lung cancer with disrupted p53 activity [Internet]. Genes & Cancer. 2014 ; 5( 1-2): 41-55.[citado 2024 abr. 24 ] Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4063255/pdf/ganc-05-041.pdf -
Vancouver
Bassères DS, Ebbs A, Cogswell PC, Baldwin AS. IKK is a therapeutic target in KRAS-induced lung cancer with disrupted p53 activity [Internet]. Genes & Cancer. 2014 ; 5( 1-2): 41-55.[citado 2024 abr. 24 ] Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4063255/pdf/ganc-05-041.pdf - Aurora kinases: potential therapeutic targets in K-Ras-induced lung cancer
- Targeted BMI1 inhibition impairs tumor growth in lung adenocarcinomas with low CEBP alpha expression
- FOXO1 inhibition by oncogenic KRAS as an important mechanism promoting lung oncogenesis
- Requirement of the NF-'capa' B subunit p65/RelA for 'capa'-Ras-induced lung tumorigenesis
- Resenha sem título próprio
- Targeting Aurora kinase activity in lung cancer cell driven by oncogenic KRAS impairs lung cancer initiating cell function
- Exploring IKKβ as an anti-angiogenic therapeutic target in KRAS-induced lung cancer
- Exploring IKKβ kinase as a therapeutic target for KRAS-driven lung tumor initiating cells
- Exploring IKKβ as an anti-metastatic therapeutic target in KRAS-induced lung cancer
- Targeting Aurora A kinase activity in lung cancer initiating cells driven by oncogenic KRAS
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
